GAM Holding’s Abiomed Inc ABMD Stock Holding History

GAM Holding’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-891	Closed	-$364K	–	993
2018 Q2	$364K	Buy	+891	New	+$323K	0.01%	761
2016 Q3	–	Sell	-3,700	Closed	-$404K	–	986
2016 Q2	$404K	Buy	+3,700	New	+$368K	0.01%	774

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

GAM Holding's ABMD Position: Q3 2018 in Review

GAM Holding sold out of Abiomed Inc (ABMD) in Q3 2018, closing a stake of 891 shares — an estimated $364K sold.

GAM Holding first reported a position in ABMD in Q2 2016 and held it in 2 quarters. The position peaked at $404K in Q2 2016. 529 funds tracked by Wall St. Rank hold ABMD as of Q3 2018.

GAM Holding reported no remaining Abiomed Inc position as of Q3 2018 after selling out during the quarter.
GAM Holding sold 891 Abiomed Inc shares in Q3 2018, an estimated $364K.
GAM Holding first reported a position in Abiomed Inc in Q2 2016 and held it in 2 quarters.
GAM Holding's Abiomed Inc position peaked at $404K in Q2 2016.
529 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2018.

Based on GAM Holding's 13F filing for Q3 2018, filed 13 Nov 2018.